ArticlePharmacoEconomics2020

Cost-Effectiveness Analysis of Patiromer in Combination with Renin-Angiotensin-Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden.

Julia Widén et al.PubMed ↗Publisher ↗

No numbers read from the abstract.